Tevogen Inc (TVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,727 | -4,283 | 1,601 | 11,265 | -60,478 |
| Depreciation Amortization | 404 | 300 | 198 | 98 | 378 |
| Accounts payable and accrued liabilities | 1,686 | 2,324 | 3,152 | 1,697 | 1,114 |
| Other Working Capital | -6 | 744 | 1,892 | 518 | 293 |
| Other Operating Activity | -355 | -8,036 | -11,990 | -15,742 | 50,521 |
| Operating Cash Flow | $-11,999 | $-8,951 | $-5,146 | $-2,164 | $-8,171 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -133 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $-133 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 1,000 | 1,000 | 0 | 0 | 4,000 |
| Other Financing Activity | 11,229 | 9,229 | 5,229 | 2,429 | -128 |
| Financing Cash Flow | $12,229 | $10,229 | $5,229 | $2,429 | $3,872 |
| Beginning Cash Position | 1,052 | 1,052 | 1,052 | 1,052 | 5,484 |
| End Cash Position | 1,283 | 2,331 | 1,135 | 1,318 | 1,052 |
| Net Cash Flow | $231 | $1,278 | $83 | $266 | $-4,432 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,999 | -8,951 | -5,146 | -2,164 | -8,171 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -133 |
| Free Cash Flow | -11,999 | -8,951 | -5,146 | -2,164 | -8,304 |